Greenman Y, Tordjman K, Kisch E, Razon N, Ouaknine G, Stern N
Institute of Endocrinology, Tel Aviv-Elias Sourasky Medical Center, Ichilov Hospital, Israel.
J Clin Endocrinol Metab. 1995 May;80(5):1577-83. doi: 10.1210/jcem.80.5.7745003.
Pre- and postoperative anterior pituitary function was assessed in 26 subjects with nonfunctioning macroadenoma (NFMA) and in 15 acromegalic subjects with macroadenomas. Preoperatively, NFMA patients had a higher prevalence of secondary hypogonadism (78% vs. 40%; P < 0.05), hypothyroidism (23% vs. 0%; P = 0.06), and hypoadrenalism (43% vs. 7%; P = 0.02) compared to individuals with GH-secreting macroadenoma (GHMA). Patients with NFMA also had a higher prevalence of more severe pituitary failure compared with acromegalic patients; 56% of the patients in this group had more than one pituitary hormone axis impaired compared to only 8% in the acromegalic group. These differences could not be accounted for by tumor grade and/or stage. Transsphenoidal pituitary surgery led to a significant improvement in anterior pituitary function in the NFMA group. Nevertheless, the prevalence of pituitary deficiency postoperatively was still significantly greater in NFMA patients than in the acromegalic group (68% vs. 17%, respectively; P < 0.04). The results suggest that anterior pituitary function is better preserved in GHMA than in NFMA and that this difference is independent of tumor size. The mechanism underlying the lower rate of hypopituitarism in acromegalics with macroadenomas remains to be elucidated.
对26例无功能大腺瘤(NFMA)患者和15例肢端肥大症大腺瘤患者术前及术后的垂体前叶功能进行了评估。术前,与生长激素分泌型大腺瘤(GHMA)患者相比,NFMA患者继发性性腺功能减退的患病率更高(78%对40%;P<0.05),甲状腺功能减退的患病率更高(23%对0%;P=0.06),肾上腺功能减退的患病率更高(43%对7%;P=0.02)。与肢端肥大症患者相比,NFMA患者严重垂体功能减退的患病率也更高;该组56%的患者有不止一个垂体激素轴受损,而肢端肥大症组只有8%。这些差异不能用肿瘤分级和/或分期来解释。经蝶窦垂体手术使NFMA组的垂体前叶功能有显著改善。然而,NFMA患者术后垂体功能减退的患病率仍显著高于肢端肥大症组(分别为68%对17%;P<0.04)。结果表明,GHMA患者的垂体前叶功能比NFMA患者保存得更好,且这种差异与肿瘤大小无关。肢端肥大症大腺瘤患者垂体功能减退发生率较低的潜在机制仍有待阐明。